Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity

After the COVID-19 pandemic, significant increases in measles cases were observed globally. Community-wide vaccination remains the most effective strategy for preventing measles. However, it is crucial to understand whether prevalent genotypes, when circulating in populations with suboptimal vaccination coverage, may undergo adaptive mutations that allow them to escape vaccine-induced immunity. In this study, a bioinformatics-guided approach was used to predict universal helper T-cell epitopes specific to the measles vaccine virus (vaccine-MeV) presented by multiple HLA-DR, -DP, and -DQ alleles to achieve population-wide coverage. By using MeV-specific T-cell lines, we identified 37 functional epitopes out of 83 predicted candidates, including 25 novel ones. Strikingly, 73% of these epitope regions were associated with sequence variations in wild-type viruses. More importantly, we demonstrated that mutations disrupted the ability of vaccine-induced CD4<sup>+</sup> T cells to respond to circulating viruses. Consequently, mutations in epitope regions of circulating viruses may affect the effectiveness of vaccine-induced T-cell immunity.

Authors

Institutions

Publication Details

Journal
npj Vaccines
Published
2025-02-20
DOI
https://doi.org/10.1038/s41541-025-01088-y
Citations
6
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
8.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity

Cécile A. C. M. van, Martijn Vos, Rik L. de Swart, Maarten E. Emmelot et al.
6 citations
npj Vaccines
Virology and Viral Diseases
8.13
article

Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity

Cécile A. C. M. van, Martijn Vos, Rik L. de Swart, Maarten E. Emmelot, Rogier Bodewes, Patricia Kaaijk, Cyril Maissan
article en
6 citations

Abstract

After the COVID-19 pandemic, significant increases in measles cases were observed globally. Community-wide vaccination remains the most effective strategy for preventing measles. However, it is crucial to understand whether prevalent genotypes, when circulating in populations with suboptimal vaccination coverage, may undergo adaptive mutations that allow them to escape vaccine-induced immunity. In this study, a bioinformatics-guided approach was used to predict universal helper T-cell epitopes specific to the measles vaccine virus (vaccine-MeV) presented by multiple HLA-DR, -DP, and -DQ alleles to achieve population-wide coverage. By using MeV-specific T-cell lines, we identified 37 functional epitopes out of 83 predicted candidates, including 25 novel ones. Strikingly, 73% of these epitope regions were associated with sequence variations in wild-type viruses. More importantly, we demonstrated that mutations disrupted the ability of vaccine-induced CD4<sup>+</sup> T cells to respond to circulating viruses. Consequently, mutations in epitope regions of circulating viruses may affect the effectiveness of vaccine-induced T-cell immunity.

npj VaccinesVol. 10(1)
Utrecht University (NL), Erasmus MC (NL), National Institute for Public Health and the Environment (NL), Erasmus University Rotterdam (NL)
Zero hunger
Openalex Percentile: Top 3%
Virology and Viral Diseases
8.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity — Cécile A. C. M. van, Martijn Vos, et al. · npj Vaccines (2025) | TGRS Research Map | TGRS